Cargando…

Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer

Colon cancer is the third most common cancer in the world and the second most common cause of cancer-related mortality. Molecular biomarkers for colon cancer have undergone vigorous discovery and validation. Recent studies reported that overexpression of podocalyxin-like protein 1 (PODXL) is associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Wen-Ying, Kuo, Chih-Chia, Lin, Bo-Xing, Cheng, Chia-Hsiung, Chen, Ku-Chung, Lin, Cheng-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666729/ https://www.ncbi.nlm.nih.gov/pubmed/28946619 http://dx.doi.org/10.3390/ijms18102047

Ejemplares similares

Podocalyxin‐Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis Pathway
por: Chen, Wei‐Ju, et al.
Publicado: (2022)

Podocalyxin-Like Protein Is Expressed in Glioblastoma Multiforme Stem-Like Cells and Is Associated with Poor Outcome
por: Binder, Zev A., et al.
Publicado: (2013)

Identification of LEA, a podocalyxin‐like glycoprotein, as a predictor for the progression of colorectal cancer
por: Yuan, Dezheng, et al.
Publicado: (2018)

Podocalyxin in Normal Tissue and Epithelial Cancer
por: Le Tran, Ngoc, et al.
Publicado: (2021)

NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma
por: Su, Po-Hsuan, et al.
Publicado: (2021)

Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis
por: Wang, Jing, et al.
Publicado: (2016)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA
por: Lee, Chin-Cheng, et al.
Publicado: (2017)

Role of podocalyxin in astrocytoma: Clinicopathological and in vitro evidence
por: HUANG, TIANXIANG, et al.
Publicado: (2013)

Podocalyxin regulates pronephric glomerular development in zebrafish
por: Ichimura, Koichiro, et al.
Publicado: (2013)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
por: Hara, M., et al.
Publicado: (2012)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
por: Larsson, Anna H, et al.
Publicado: (2013)

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling
por: Fröse, Julia, et al.
Publicado: (2018)

Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit
por: Kuo, Chih-Chia, et al.
Publicado: (2019)

Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
por: Li, Ying-Wei, et al.
Publicado: (2018)

IGF-1-enhanced miR-513a-5p signaling desensitizes glioma cells to temozolomide by targeting the NEDD4L-inhibited Wnt/β-catenin pathway
por: Chen, Ku-Chung, et al.
Publicado: (2019)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy
por: Imaizumi, Takahiro, et al.
Publicado: (2016)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via β-Catenin Signaling
por: Liu, Yu, et al.
Publicado: (2014)

Ameboma: A Colon Carcinoma-Like Lesion in a Colonoscopy Finding
por: Lin, Chung-Cheng, et al.
Publicado: (2013)

Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond
por: Pontes, Bruno, et al.
Publicado: (2023)

Involvement of Platelet–Tumor Cell Interaction in Immune Evasion. Potential Role of Podocalyxin-Like Protein 1
por: Amo, Laura, et al.
Publicado: (2014)

Podocalyxin‐like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin
por: Taniuchi, Keisuke, et al.
Publicado: (2016)

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2018)

TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties
por: Tiffon, Camille, et al.
Publicado: (2020)

Correction: Podocalyxin Promotes Glioblastoma Multiforme Cell Invasion and Proliferation via β-Catenin Signaling
Publicado: (2015)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition
por: Meng, Xiaobo, et al.
Publicado: (2011)

Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide
por: WU, HAO, et al.
Publicado: (2013)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death
por: Chen, Peng-Hsu, et al.
Publicado: (2016)

A medium hyperglycosylated podocalyxin enables noninvasive and quantitative detection of tumorigenic human pluripotent stem cells
por: Tateno, Hiroaki, et al.
Publicado: (2014)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome
por: Kang, Hee Gyung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p8imr0ssvalu8va21v9fihsj3h